Citations (7)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Felipe de Queiroz Tavares Ferreira, Daniel Cunha Araújo, Leonardo Mendonça de Albuquerque, Priscila Monaro Bianchini, Erick Carneiro Holanda & Alisson Pugliesi. (2023) Possible Association between Vogt-Koyanagi-Harada Disease and Coronavirus Disease Vaccine: A Report of Four Cases. Ocular Immunology and Inflammation 31:6, pages 1134-1140.
Read now
Read now
Elif Arslanoglu Aydin, Semanur Ozdel, Pinar Cakar Ozdal, İlknur Bagrul, Esra Baglan, Serife Tuncez & Mehmet Bulbul. (2023) Changing face of non-infectious pediatric uveitis in the pre-pandemic and pandemic periods: a comparison study. Postgraduate Medicine 135:4, pages 418-423.
Read now
Read now
Articles from other publishers (5)
Joanne Thomas, Nam V. Nguyen, Tolulope Fashina, Ye Huang, Steven Yeh & Christopher D. Conrady. (2023) An update on immunological and molecular tests and their impact in infectious uveitis. Frontiers in Ophthalmology 3.
Crossref
Crossref
Jessica Shantha, Amit K. Reddy, Amol Sura, Adrian Tsang, Kareem Moussa, Nisha Acharya, John Gonzales & Thuy Doan. (2022) Bilateral anterior and intermediate uveitis in SARS-CoV-2 associated multisystem inflammatory syndrome in a pediatric patient. Pediatric Rheumatology 20:1.
Crossref
Crossref
Swati Barne S, Joshi Devika S & Beke Nikhil N. (2022) A case report of bilateral, symmetrical intermediate uveitis in a post COVID 19 Indian patient. Indian Journal of Clinical and Experimental Ophthalmology 8:2, pages 308-310.
Crossref
Crossref
Toshihiko Matsuo, Hiroyuki Honda, Takehiro Tanaka, Kensuke Uraguchi, Masaaki Kawahara & Hideharu Hagiya. (2022) COVID-19 mRNA Vaccine–Associated Uveitis Leading to Diagnosis of Sarcoidosis: Case Report and Review of Literature. Journal of Investigative Medicine High Impact Case Reports 10, pages 232470962210864.
Crossref
Crossref
Roma Ghai, Kandasamy Nagarajan, Tejesvi Mishra, Srishti Vats & Abhimanyu Kaushik. Evolving pharmaceutical therapies for confronting COVID-19: An overview. Evolving pharmaceutical therapies for confronting COVID-19: An overview.